Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""immunotherapy"" wg kryterium: Temat


Starter badań:

Tytuł :
The Role of T Cell Immunotherapy in Acute Myeloid Leukemia.
Autorzy :
Hao F; Center for Precision Medicine, Department of Medicine, University of Missouri, 1 Hospital Drive, Columbia, MI 65212, USA.
Sholy C; Center for Precision Medicine, Department of Medicine, University of Missouri, 1 Hospital Drive, Columbia, MI 65212, USA.
Wang C; Center for Precision Medicine, Department of Medicine, University of Missouri, 1 Hospital Drive, Columbia, MI 65212, USA.
Cao M; Center for Precision Medicine, Department of Medicine, University of Missouri, 1 Hospital Drive, Columbia, MI 65212, USA.
Kang X; Center for Precision Medicine, Department of Medicine, University of Missouri, 1 Hospital Drive, Columbia, MI 65212, USA.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Dec 01; Vol. 10 (12). Date of Electronic Publication: 2021 Dec 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Immunotherapy*
Leukemia, Myeloid, Acute/*immunology
Leukemia, Myeloid, Acute/*therapy
T-Lymphocytes/*immunology
Animals ; Clinical Trials as Topic ; Humans ; Immunotherapy, Adoptive ; Models, Biological
Czasopismo naukowe
Tytuł :
Natural Killer Cells in Cancer and Cancer Immunotherapy.
Autorzy :
Raskov H; Center for Surgical Science, Zealand University Hospital, Lykkebækvej 1, DK-4600, Køge, Denmark. Electronic address: .
Orhan A; Center for Surgical Science, Zealand University Hospital, Lykkebækvej 1, DK-4600, Køge, Denmark; Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark. Electronic address: .
Salanti A; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2200, Copenhagen, Denmark. Electronic address: .
Gaggar S; Center for Surgical Science, Zealand University Hospital, Lykkebækvej 1, DK-4600, Køge, Denmark. Electronic address: .
Gögenur I; Center for Surgical Science, Zealand University Hospital, Lykkebækvej 1, DK-4600, Køge, Denmark; Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Nov 01; Vol. 520, pp. 233-242. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunotherapy*
Killer Cells, Natural/*immunology
Neoplasms/*therapy
Receptors, Chimeric Antigen/*immunology
CD8-Positive T-Lymphocytes/immunology ; Humans ; Immunotherapy, Adoptive/trends ; Neoplasms/genetics ; Neoplasms/immunology ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/therapeutic use
Czasopismo naukowe
Tytuł :
Antigen Loss after Targeted Immunotherapy in Hematological Malignancies.
Autorzy :
Zhou T; Flow Cytometry Unit, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Wang HW; Flow Cytometry Unit, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: .
Pokaż więcej
Źródło :
Clinics in laboratory medicine [Clin Lab Med] 2021 Sep; Vol. 41 (3), pp. 341-357. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Review
MeSH Terms :
Hematologic Neoplasms*/therapy
Immunotherapy, Adoptive*
Humans ; Immunotherapy ; Tumor Escape
Czasopismo naukowe
Tytuł :
The State of Immunotherapy in Hepatobiliary Cancers.
Autorzy :
Ilyas FZ; College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.; The James Comprehensive Cancer Center, Columbus, OH 43210, USA.
Beane JD; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.; The James Comprehensive Cancer Center, Columbus, OH 43210, USA.
Pawlik TM; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.; The James Comprehensive Cancer Center, Columbus, OH 43210, USA.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Aug 15; Vol. 10 (8). Date of Electronic Publication: 2021 Aug 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunotherapy*
Biliary Tract Neoplasms/*therapy
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*therapy
Antibodies, Bispecific/therapeutic use ; Cancer Vaccines/therapeutic use ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy, Adoptive ; Oncolytic Viruses ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł :
Role of salivary microbiome in IL-10 production and efficacy of sublingual immunotherapy.
Autorzy :
Oka A; Department of Otorhinolaryngology, International University of Health and Welfare Graduate School of Medicine, Narita, Japan.
Kidoguchi M; Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.; Department of Medical Genetics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Kariya S; Departments of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Fujiwara T; Departments of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Yuta A; Yuta Clinic, Tsu, Japan.
Miyashita H; Yuta Clinic, Tsu, Japan.
Higaki T; Departments of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Ogawa Y; Yuta Clinic, Tsu, Japan.
Kanai K; Department Otorhinolaryngology-Head & Neck Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Makihara SI; Department Otorhinolaryngology-Head & Neck Surgery, Kagawa Rosai Hospital, Marugame, Japan.
Haruna T; Department Otorhinolaryngology, Himeji St. Mary's Hospital, Himeji, Japan.
Kunisawa J; Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
Adachi N; Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.; Department of Medical Genetics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Koyama K; Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Ii R; Department of Medical Genetics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Noguchi E; Department of Medical Genetics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Fujieda S; Department of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Nishizaki K; Departments of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Okano M; Department of Otorhinolaryngology, International University of Health and Welfare Graduate School of Medicine, Narita, Japan.; Departments of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Pokaż więcej
Źródło :
Allergy [Allergy] 2021 Aug; Vol. 76 (8), pp. 2617-2620. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Microbiota*
Rhinitis, Allergic*
Rhinitis, Allergic, Seasonal*
Sublingual Immunotherapy*
Humans ; Immunotherapy ; Interleukin-10 ; Treatment Outcome
Raport
Tytuł :
Immunotherapeutic advances in gastric cancer.
Autorzy :
Yoneda A; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8501, Japan. .; Department of Surgery, National Hospital Organization Nagasaki Medical Center, Nagasaki, 856-0835, Japan. .
Kuroki T; Department of Surgery, National Hospital Organization Nagasaki Medical Center, Nagasaki, 856-0835, Japan.
Eguchi S; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8501, Japan.
Pokaż więcej
Źródło :
Surgery today [Surg Today] 2021 Nov; Vol. 51 (11), pp. 1727-1735. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunotherapy/*methods
Immunotherapy/*trends
Stomach Neoplasms/*therapy
B7-H1 Antigen/immunology ; CTLA-4 Antigen/immunology ; Cancer Vaccines/therapeutic use ; Combined Modality Therapy ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy, Adoptive ; Stomach Neoplasms/mortality ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Cell Fate Reprogramming in the Era of Cancer Immunotherapy.
Autorzy :
Zimmermannova O; Cell Reprogramming in Hematopoiesis and Immunity Laboratory, Lund Stem Cell Center, Department of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Caiado I; Cell Reprogramming in Hematopoiesis and Immunity Laboratory, Lund Stem Cell Center, Department of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.; Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Coimbra, Portugal.
Ferreira AG; Cell Reprogramming in Hematopoiesis and Immunity Laboratory, Lund Stem Cell Center, Department of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.; Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Coimbra, Portugal.
Pereira CF; Cell Reprogramming in Hematopoiesis and Immunity Laboratory, Lund Stem Cell Center, Department of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.; Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jul 21; Vol. 12, pp. 714822. Date of Electronic Publication: 2021 Jul 21 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Immunotherapy*/adverse effects
Immunotherapy*/methods
Molecular Targeted Therapy*/methods
Antineoplastic Agents, Immunological/*therapeutic use
Cellular Reprogramming/*genetics
Cellular Reprogramming/*immunology
Neoplasms/*etiology
Neoplasms/*therapy
Animals ; Antineoplastic Agents, Immunological/pharmacology ; Cancer Vaccines/therapeutic use ; Cellular Reprogramming Techniques ; Combined Modality Therapy ; Disease Management ; Genetic Engineering ; Genetic Therapy ; Humans ; Immunotherapy, Adoptive
Czasopismo naukowe
Tytuł :
Nonclinical safety assessment of engineered T cell therapies.
Autorzy :
Lebrec H; Amgen, South San Francisco, CA, United States. Electronic address: .
Maier CC; GlaxoSmithKline, Collegeville, PA, United States.
Maki K; Pharmaceutical and Medical Device Agency, Tokyo, Japan.
Ponce R; Shape Therapeutics Incorporated, Seattle, WA, United States.
Shenton J; Janssen Research and Development, Spring House, PA, United States.
Green S; Umoja Biopharma Incorporated, Seattle, WA, United States.
Pokaż więcej
Źródło :
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2021 Dec; Vol. 127, pp. 105064. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cell Engineering/*methods
Immunotherapy/*adverse effects
Immunotherapy/*methods
T-Lymphocytes/*immunology
Cytokine Release Syndrome/physiopathology ; Gene Editing ; Immunotherapy, Adoptive/adverse effects ; Neurotoxicity Syndromes/physiopathology ; Receptors, Antigen, T-Cell/physiology ; Risk Assessment
Czasopismo naukowe
Tytuł :
Development of humanized mouse with patient-derived xenografts for cancer immunotherapy studies: A comprehensive review.
Autorzy :
Jin KT; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Du WL; Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Lan HR; Department of Breast and Thyroid Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Liu YY; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Mao CS; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Du JL; Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Mou XZ; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Jul; Vol. 112 (7), pp. 2592-2606. Date of Electronic Publication: 2021 Jun 05.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Disease Models, Animal*
Immunotherapy*
Xenograft Model Antitumor Assays*
Neoplasms/*therapy
Animals ; Antibodies, Monoclonal/therapeutic use ; Cytokines/metabolism ; Drug Development ; Genetic Engineering ; Graft Rejection/immunology ; Graft vs Host Disease/prevention & control ; Humans ; Immunotherapy, Adoptive/methods ; Intercellular Signaling Peptides and Proteins/metabolism ; Killer Cells, Natural/immunology ; Mice ; Mice, SCID ; Neoplasms/immunology ; Precision Medicine ; Translational Research, Biomedical ; Transplantation, Heterologous
Czasopismo naukowe
Tytuł :
Infusion reactions in natural killer cell immunotherapy: a retrospective review.
Autorzy :
Mamo T; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
Williams SM; Department of Pathology and Microbiology, Nebraska Medical Center, Omaha, Nebraska, USA.
Kinney S; Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Tessier KM; Masonic Cancer Center Biostatistics Core, University of Minnesota, Minneapolis, Minnesota, USA.
DeFor TE; Masonic Cancer Center Biostatistics Core, University of Minnesota, Minneapolis, Minnesota, USA.
Cooley S; Fate Therapeutics, San Diego, California, USA.
Miller JS; Department of Medicine, Division of Hematology, Oncology, and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
McKenna DH; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: .
Pokaż więcej
Źródło :
Cytotherapy [Cytotherapy] 2021 Jul; Vol. 23 (7), pp. 627-634. Date of Electronic Publication: 2021 May 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Immunotherapy*/adverse effects
Killer Cells, Natural*
Humans ; Immunotherapy, Adoptive ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Differentiation and Regulation of T H Cells: A Balancing Act for Cancer Immunotherapy.
Autorzy :
Basu A; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.
Ramamoorthi G; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.
Albert G; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.
Gallen C; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.
Beyer A; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.
Snyder C; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.
Koski G; Department of Biological Sciences, Kent State University, Kent, OH, United States.
Disis ML; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, WA, United States.
Czerniecki BJ; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.; Department of Oncological Sciences, University of South Florida, Tampa, FL, United States.; Department of Breast Cancer Program, Moffitt Cancer Center, Tampa, FL, United States.
Kodumudi K; Clinical Science Division, Moffitt Cancer Center, Tampa, FL, United States.; Department of Biological Sciences, Kent State University, Kent, OH, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 May 03; Vol. 12, pp. 669474. Date of Electronic Publication: 2021 May 03 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms :
Immunotherapy*/adverse effects
Lymphocytes, Tumor-Infiltrating/*immunology
Neoplasms/*therapy
T-Lymphocytes, Cytotoxic/*immunology
T-Lymphocytes, Helper-Inducer/*immunology
Tumor Microenvironment/*immunology
Animals ; Antigens, Neoplasm/metabolism ; Cancer Vaccines/therapeutic use ; Cell Differentiation ; Cytokines/metabolism ; Cytotoxicity, Immunologic ; Humans ; Immunotherapy, Adoptive ; Lymphocyte Activation ; Lymphocytes, Tumor-Infiltrating/metabolism ; Neoplasms/immunology ; Neoplasms/metabolism ; Neoplasms/pathology ; Phenotype ; Signal Transduction ; T-Lymphocytes, Cytotoxic/metabolism ; T-Lymphocytes, Helper-Inducer/metabolism
Czasopismo naukowe
Tytuł :
Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases.
Autorzy :
Elkhalifa D; Department of Pharmacy, Aspetar Orthopedic and Sports Medicine Hospital, Doha, Qatar.
Rayan M; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Negmeldin AT; Department of Pharmaceutical Sciences, College of Pharmacy and Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Elhissi A; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar; Office of the Vice President for Research and Graduate Studies, Qatar University, Doha, Qatar.
Khalil A; Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Jan; Vol. 145, pp. 112385. Date of Electronic Publication: 2021 Oct 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Vaccines, Synthetic*/administration & dosage
Vaccines, Synthetic*/immunology
mRNA Vaccines*/administration & dosage
mRNA Vaccines*/immunology
COVID-19/*prevention & control
Chronic Disease/*prevention & control
Chronic Disease/*therapy
Genetic Therapy/*methods
Immunotherapy/*methods
Pandemics/*prevention & control
RNA, Messenger/*chemistry
SARS-CoV-2/*immunology
Biological Availability ; Drug Carriers ; Forecasting ; Gene Transfer Techniques ; Genetic Vectors/administration & dosage ; Genetic Vectors/therapeutic use ; Humans ; Immunotherapy, Active ; Nanoparticle Drug Delivery System ; RNA Stability ; RNA, Messenger/administration & dosage ; RNA, Messenger/immunology ; RNA, Messenger/therapeutic use ; SARS-CoV-2/genetics ; Vaccine Development
Czasopismo naukowe
Tytuł :
Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells.
Autorzy :
Charo J; F. Hoffmann-La Roche AG, Pharmaceutical Research and Early Development Oncology, Roche Innovation Center Zurich, Zurich, Switzerland. .
Gomes B; F. Hoffmann-La Roche AG, Pharmaceutical Research and Early Development Oncology, Roche Innovation Center Basel, Basel, Switzerland.
Pokaż więcej
Źródło :
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2021 Jul 28; Vol. 6 (1), pp. 286. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Immunotherapy*
Neoplasms*/therapy
Immunotherapy, Adoptive ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
Innate lymphoid cells type 2 in LTP-allergic patients and their modulation during sublingual immunotherapy.
Autorzy :
Palomares F; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
Gómez F; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Bogas G; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Maggi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Cosmi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Annunziato F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Núñez R; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
Pérez N; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Muñoz-Cano R; Allergy Section, Pneumology Department, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
Torres MJ; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Medicine Department, Universidad de Málaga-UMA, Málaga, Spain.
Mayorga C; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Pokaż więcej
Źródło :
Allergy [Allergy] 2021 Jul; Vol. 76 (7), pp. 2253-2256. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Hypersensitivity*/therapy
Rhinitis, Allergic*
Sublingual Immunotherapy*
Allergens ; Animals ; Humans ; Immunity, Innate ; Immunotherapy ; Lymphocytes ; Pyroglyphidae
Raport
Tytuł :
Ophthalmic Implications of Chimeric Antigen Receptor T-Cell Therapy.
Autorzy :
Chodnicki KD; Massachusetts Eye and Ear, Department of Ophthalmology, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Prasad S; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA.
Pokaż więcej
Źródło :
Seminars in ophthalmology [Semin Ophthalmol] 2021 May 19; Vol. 36 (4), pp. 329-334. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunotherapy, Adoptive*
Receptors, Chimeric Antigen*
Cell- and Tissue-Based Therapy ; Humans ; Immunotherapy ; Receptors, Antigen, T-Cell/genetics
Czasopismo naukowe
Tytuł :
A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.
Autorzy :
Upadhyay R; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Boiarsky JA; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Pantsulaia G; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Svensson-Arvelund J; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Lin MJ; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Wroblewska A; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Bhalla S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Scholler N; Kite Pharma, Santa Monica, California.
Bot A; Kite Pharma, Santa Monica, California.
Rossi JM; Kite Pharma, Santa Monica, California.
Sadek N; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Parekh S; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Lagana A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Baccarini A; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Merad M; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Brown BD; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Brody JD; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York. .; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Pokaż więcej
Źródło :
Cancer discovery [Cancer Discov] 2021 Mar; Vol. 11 (3), pp. 599-613. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cytotoxicity, Immunologic*
Immunotherapy*/adverse effects
Immunotherapy*/methods
T-Lymphocytes/*immunology
T-Lymphocytes/*metabolism
fas Receptor/*metabolism
Animals ; Antigens, Neoplasm/immunology ; Bystander Effect/immunology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; CRISPR-Cas Systems ; Disease Models, Animal ; Gene Editing ; Genetic Engineering ; Humans ; Immunotherapy, Adoptive/adverse effects ; Immunotherapy, Adoptive/methods ; Mice ; Mice, Knockout ; Neoplasms/etiology ; Neoplasms/therapy ; Receptors, Chimeric Antigen ; T-Cell Antigen Receptor Specificity ; Treatment Outcome ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Immunotherapy of gastric cancer: Past, future perspective and challenges.
Autorzy :
Xie J; Department of Gastroenterology Surgery, Affiliated Hospital of Shaoxing University, Shaoxing 312000, Zhejiang Province, China.
Fu L; Department of Nuclear Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Jin L; Department of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China. Electronic address: .
Pokaż więcej
Źródło :
Pathology, research and practice [Pathol Res Pract] 2021 Feb; Vol. 218, pp. 153322. Date of Electronic Publication: 2020 Dec 24.
Typ publikacji :
Historical Article; Journal Article; Review
MeSH Terms :
Immunotherapy*/history
Immunotherapy*/trends
Lymphocytes, Tumor-Infiltrating/*immunology
Stomach Neoplasms/*therapy
T-Lymphocytes, Cytotoxic/*immunology
Tumor Microenvironment/*immunology
Animals ; Antibodies, Monoclonal/therapeutic use ; Antineoplastic Agents, Immunological/therapeutic use ; Cancer Vaccines/therapeutic use ; Cytotoxicity, Immunologic ; Diffusion of Innovation ; Forecasting ; History, 20th Century ; History, 21st Century ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy, Adoptive ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/metabolism ; Stomach Neoplasms/immunology ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/pathology ; T-Lymphocytes, Cytotoxic/drug effects ; T-Lymphocytes, Cytotoxic/metabolism ; Tumor Escape
Czasopismo naukowe
Tytuł :
Exploring novel systemic biomarker approaches in grass-pollen sublingual immunotherapy using omics.
Autorzy :
Barker-Tejeda TC; Facultad de Farmacia, Centro de Metabolómica y Bioanálisis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Madrid, España.; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Bazire R; Servicio de Alergia, Instituto de Investigación Sanitaria Princesa (IP), Hospital Universitario de La Princesa, Madrid, España.; Servicio de Alergia, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Niño Jesús, Madrid, España.
Obeso D; Facultad de Farmacia, Centro de Metabolómica y Bioanálisis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Madrid, España.; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Mera-Berriatua L; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Rosace D; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Vazquez-Cortes S; Servicio de Alergia, Hospital Clínico San Carlos, Universidad Complutense, IdISSC, Madrid, España.
Ramos T; Servicio de Alergia, Instituto de Investigación Sanitaria Princesa (IP), Hospital Universitario de La Princesa, Madrid, España.
Rico MDP; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Chivato T; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Barbas C; Facultad de Farmacia, Centro de Metabolómica y Bioanálisis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Madrid, España.
Villaseñor A; Facultad de Farmacia, Centro de Metabolómica y Bioanálisis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Madrid, España.; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Escribese MM; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Fernández-Rivas M; Servicio de Alergia, Hospital Clínico San Carlos, Universidad Complutense, IdISSC, Madrid, España.
Blanco C; Servicio de Alergia, Instituto de Investigación Sanitaria Princesa (IP), Hospital Universitario de La Princesa, Madrid, España.
Barber D; Facultad de Medicina, Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, España.
Pokaż więcej
Źródło :
Allergy [Allergy] 2021 Apr; Vol. 76 (4), pp. 1199-1212. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Rhinitis, Allergic, Seasonal*/diagnosis
Rhinitis, Allergic, Seasonal*/therapy
Sublingual Immunotherapy*
Allergens ; Biomarkers ; Desensitization, Immunologic ; Double-Blind Method ; Humans ; Immunotherapy ; Poaceae ; Pollen
Czasopismo naukowe
Tytuł :
Targeting loss of heterozygosity for cancer-specific immunotherapy.
Autorzy :
Hwang MS; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Mog BJ; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218.
Douglass J; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Pearlman AH; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Hsiue EH; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Paul S; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
DiNapoli SR; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Konig MF; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224.
Pardoll DM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21287.
Gabelli SB; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Bettegowda C; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Papadopoulos N; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.; Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Vogelstein B; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; HHMI, Chevy Chase, MD 20815.; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21287.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.; Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Zhou S; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287; .; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21287.
Kinzler KW; Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287; .; Lustgarten Laboratory for Pancreatic Cancer Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21287.; Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Mar 23; Vol. 118 (12).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor*
Immunotherapy*/methods
Loss of Heterozygosity*
Molecular Targeted Therapy*/adverse effects
Molecular Targeted Therapy*/methods
Neoplasms/*etiology
Neoplasms/*therapy
Alleles ; Antigens, Neoplasm/immunology ; Cell- and Tissue-Based Therapy ; HLA Antigens/genetics ; HLA Antigens/immunology ; Humans ; Immunotherapy, Adoptive ; Single-Chain Antibodies/pharmacology ; Single-Chain Antibodies/therapeutic use
Czasopismo naukowe
Tytuł :
Current Immunotherapies for Glioblastoma Multiforme.
Autorzy :
Huang B; Department of Neurosurgery, Beijing Electric Power Hospital, Beijing, China.
Li X; Department of Neurosurgery, Huizhou Third People's Hospital, Guangzhou Medical University, Huizhou, China.
Li Y; Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Guangzhou, China.
Zhang J; Department of Neurosurgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Zong Z; Department of Neurosurgery, Jiujiang Hospital of Traditional Chinese Medicine, Jiujiang, China.
Zhang H; Department of Neurosurgery, Huizhou Third People's Hospital, Guangzhou Medical University, Huizhou, China.; Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Guangzhou, China.; Department of Neurosurgery, Jiujiang Hospital of Traditional Chinese Medicine, Jiujiang, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Mar 09; Vol. 11, pp. 603911. Date of Electronic Publication: 2021 Mar 09 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Immunotherapy*
Brain Neoplasms/*therapy
Glioblastoma/*therapy
Animals ; Brain Neoplasms/immunology ; Brain Neoplasms/metabolism ; Cancer Vaccines/therapeutic use ; Glioblastoma/immunology ; Glioblastoma/metabolism ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy, Adoptive ; Molecular Targeted Therapy ; Oncolytic Virotherapy ; Treatment Outcome ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies